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A global  research and development partnership to reduce 




Provide technical facilities to foster 
collaborations 
Facilities for capacity development
Online information platform
Coordinate communication on 
agriculture-associated AMR
Data storage and biobank











The CGIAR Antimicrobial Resistance Hub
applies a One Health approach to contribute
to mitigating the effects of antimicrobial
resistance (AMR) globally, and to support the
efforts of low- and middle-income countries
(LMIC’s) in controlling agriculture-associated
AMR risks through promoting and facilitating
transdisciplinary partnerships.
The AMR hub generates evidence on links
between agriculture and public health outcomes
and develops solutions that are locally relevant
and applicable. Research on how to best
implement and scale workable solutions is
embedded in capacity development activities and
supported through advocacy for enabling
policies. These ambitions need effective
partnerships across disciplines, which are at the
heart of the AMR hub.
We research behaviour around antimicrobial used, 
the distribution networks of antimicrobials, and the 
role of formal and informal markets in perpetuating 
cycles of inequity
Outputs: 
• Metrics for AM use in different systems
• Better understanding of systems influencing AM 
use behaviour
Benefits
• New significant transdisciplinary partnerships around AMR
• Urgently needed evidence on ways to mitigate agri-food 
system associated AMR risks
• Strengthened advocacy and communication on agri-food 
system associated AMR
• Compelling evidence and support for donors on critical 
AMR research gaps in LMICs
•A growing, well-managed  CGIAR AMR research portfolio 
facilitating collaboration between CGIAR centers and CGIAR 
research programs
• Improved access for national science partners to 
international AMR research community
To better understand AMR risks for people, 
we study the biology, ecology, and 
epidemiology of resistant microbes at the 
animal, human  and environment interface. 
Outputs
• adequate study designs for 
genotyping research
• evidence on the extent of 
resistant bacteria and 
antimicrobial residues found in 
livestock, fish, humans, the 
environment, water and food 
• transmission and genetic 
mechanisms of resistance in 
agriculture and the implications 
for human and animal health
Based on One Health 
approaches, we design, 
test and evaluate 
interventions and 
incentives that lead to 




• Typologies of interventions
• Decision support tools to identify best-bet interventions
• Gender sensitive interventions to mange drivers of AM 
use
• Cost and benefits of interventions from a One Health 
perspective
Supported by
We translate evidence 
into convincing 
arguments to engage 
policymakers and other 
stakeholders in the 
AMR discussion. 
Accepted and feasible 
policies are key for 
sustainable solutions 
that achieve impact. 
Outputs
• Synthesized evidence for policy makers
• Advocacy materials
• Integrated policy approaches towards One Health 
solutions
Capacity development as a key enabler on 
the pathway to impact. We capitalize on a 
network of AMR experts to support capacity 
building on researching AMR issues and to
Outputs
• Guidance for scaling of 
interventions 




facilitate access to international AMR 
research for professionals and 
institutions in LMICs.
An important area of research is how 
solutions can be brought to scale.
For more information
